Maria Palasis - Jun 15, 2023 Form 4/A - Amendment Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
President & CEO, Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Maria Palasis, Ph.D.
Stock symbol
LYRA
Transactions as of
Jun 15, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/12/2023, 06:36 PM
Date Of Original Report
Jun 26, 2023
Previous filing
Feb 2, 2023
Next filing
Mar 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYRA Stock Option Award $0 +150K $0.00 150K Jun 15, 2023 Common Stock 150K $2.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following June 15, 2023.
F2 This Form 4 amendment is being filed to correct the expiration date of the stock option granted to the Reporting Person.